We are live on ! Find out more
FCMI

Foresite Capital Management II Portfolio holdings

AUM $29.2M
1-Year Est. Return 44.84%
This Fund
S&P 500
This Quarter Est. Return
+8%
1 Year Est. Return
+44.84%
3 Year Est. Return
-66.21%
5 Year Est. Return
-36.36%
10 Year Est. Return
–
AUM
$372M
AUM Growth
-$63.3M
Cap. Flow
-$90.5M
Cap. Flow %
-24.34%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TXG icon
10x Genomics
TXG
+$90.5M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXG icon
1
10x Genomics
TXG
$5.87B
$343M 92.37%
1,753,528
-500,000
-22% -$90.5M
NVAX icon
2
Novavax
NVAX
$1.23B
$14.3M 3.85%
67,373
– –
EPZM
3
DELISTED
Epizyme, Inc
EPZM
$8.31M 2.24%
1,000,002
– –
XLRN
4
DELISTED
Acceleron Pharma
XLRN
$5.76M 1.55%
45,884
– –

Similar funds

AG
Appleton Group Appleton, Wisconsin $28.6M AUM 32.21% 1-Year Est. Return
SAM
Sandbar Asset Management London, United Kingdom $30.5M AUM 46.07% 1-Year Est. Return
AC
Amia Capital London, United Kingdom $32.1M AUM 0.56% 1-Year Est. Return
QI
Qualcomm Inc San Diego, California $32.1M AUM 5.35% 1-Year Est. Return
TAAM
Top Ace Asset Management Hong Kong $25.3M AUM 23.27% 1-Year Est. Return
NAM
Nationwide Asset Management Columbus, Ohio $25.1M AUM 13.37% 1-Year Est. Return
MSKCC
Memorial Sloan Kettering Cancer Center New York $24.6M AUM 10.16% 1-Year Est. Return
BRC
Bishop Rock Capital New York $24.3M AUM 20.73% 1-Year Est. Return

Foresite Capital Management II's Q2 2021 Portfolio in Review

As of Q2 2021, Foresite Capital Management II held 4 positions worth $372M, down 15% from $435M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management II withdrew a net $90.5M in Q2 2021, reducing 1 holding. Its largest reduction was 10x Genomics, cutting an estimated $90.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management II's biggest Q2 2021 reduction was 10x Genomics, cutting an estimated $90.5M.
  • Foresite Capital Management II's ten largest holdings make up 100% of its $372M portfolio in Q2 2021.
  • Foresite Capital Management II opened 0 new positions and closed 0 in Q2 2021.
  • Foresite Capital Management II's portfolio value fell 15% quarter-over-quarter to $372M.

Based on Foresite Capital Management II's 13F filing for Q2 2021, filed 16 Aug 2021.